Jessica Lill
Family · Worthington, OHNPI 1427409283
Payments from drug & device makers
Across 52 payments — averaging $13.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$217
- Novartis$71
- Lilly USA, LLC$63
- Amarin Pharma, Inc.$42
- Johnson & Johnson$39
- AstraZeneca$39
- plus $253 from 11 others
What the payments were for
- Food & beverage$725100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $217 |
| Novartis | 5 | $71 |
| Lilly USA, LLC | 4 | $63 |
| Amarin Pharma, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $39 |
| AstraZeneca | 3 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Boehringer Ingelheim | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $31 |
| Bayer | 2 | $30 |
| Astellas Pharma US Inc | 1 | $19 |
| Merck | 1 | $16 |
| Amgen | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$725 in reported general payments places this provider in the 65th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $18,975 |
| Atorvastatin Calcium | 174 | $1,249 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,026 |
| Levothyroxine Sodium | 120 | $780 |
| Omeprazole | 54 | $753 |
| Metoprolol Succinate | 56 | $566 |
| Losartan Potassium | 83 | $555 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 32 | $501 |
| Amlodipine Besylate | 103 | $496 |
| Lisinopril | 89 | $478 |
| Fluticasone Propionate | 30 | $415 |
| Potassium Chloride | 20 | $406 |
| Gabapentin | 25 | $374 |
| Metoprolol Tartrate | 59 | $348 |
| Famotidine | 30 | $344 |
Paid to pharmacies, not to this prescriber.
Other family in Worthington
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.